Trabecular bone score (TBS), which has been shown to discriminate patients with fractures from healthy individuals, decreases with age. This study was conducted to derive an age-adjusted normative TBS curve for each gender aged 30-80 + years to serve as reference data for Thai males and females. A cross-sectional study was conducted among employees from the Electricity Generating Authority of Thailand cohorts, after excluding those with conditions potentially affecting bone metabolism and analysis. The values of TBS at L1-L4 vertebrae were analyzed using a commercial software. Age-adjusted TBS curves were constructed using segmental linear regression analysis for each gender. Additional analysis was also performed on TBS with age, body mass index, and body mineral density (BMD) at L1-L4 vertebrae as covariates. A database of 848 healthy subjects (341 females and 507 males) aged 30-80+ years was created. The BMDs of both male and female subjects in the youngest decade were not statistically different from previous reports (p = 0.31 and 0.22 for females and males, respectively). In this age group, the mean TBS was higher in females, albeit not statistically significant (p = 0.12). Between the ages of 30-80+ years, female and male TBS dropped by 19.8% (0.40% per year) and 10.1% (0.20% per year), respectively. The association with TBS was weak for body mass index and moderate for BMD (coefficients of about -0.01 and 0.4-0.5, respectively). The age-adjusted reference curves for healthy Thai females and males aged 30-80+ years have been established.

First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach - Molecular Imaging and Radionuclide Therapy

OBJECTIVE The objective of this study is to compute the precision and LSC of BMD and TBS at the lumbar spine using dual-energy X-ray absorptiometry in different vertebral combinations. METHODS Thirty female participants (age 58.8 ± 4.0 years, height: 155.0 ± 5.2 cm, weight: 57.4 ± 8.6 kg and BMI: 23.9 ± 3.6) were scanned at the lumbar spine twice in the same day using DXA. The precision and LSC of BMD and TBS were computed in terms of the RMS-SD and %CV using the ISCD Advanced Precision Calculation Tool. RESULTS The precision and LSC of BMD of the 4 vertebrae combinations showed the best precision and also showed a similar trend (0.005 g/cm2 and 0.62%, 0.013 g/cm2 and 1.71%), respectively. For TBS, the precision and LSC followed a similar pattern as BMD but was inferior to those of BMD. The %CV LSC of BMD for all vertebrae combinations did not exceed 5.3% as recommended by ISCD (15). The %CV LSC of TBS for 2-4 vertebrae combinations were within 5.8% with the exception of the individual vertebra which was unacceptable (%CV range 6.17-8.98). CONCLUSIONS All vertebrae combinations had an acceptable level of precision and LSC for BMD monitoring. However, the precision and LSC of TBS were inferior to those of BMD, and individual vertebra were not appropriate for TBS monitoring. KEYWORDS precision, least significant change (LSC), bone mineral density (BMD), trabecular bone score (TBS)

Nuclear medicine investigations play a significant role in diagnosing dementia, mainly using imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT). By providing functional and molecular data via brain imaging, nuclear medicine investigations offer valuable insights that complement clinical evaluations and structural imaging in the early detection, diagnosis, and differentiation of various types of dementia, leading to more accurate diagnosis and personalized treatment planning. Therefore, the Nuclear Medicine Society of Thailand, the Neurological Society of Thailand, and the Thai Medical Physicist Society have collaborated to establish these practical nuclear medicine investigation guidelines aiming to (1) identify the role of nuclear medicine studies in patients with neurocognitive disorders; (2) assist referrers in requesting the most appropriate procedure for diagnosis of each type of neurocognitive disorders; and (3) identify scientific evidence that is useful to assisting nuclear medicine professionals in recommending, performing, interpreting, and reporting the results of nuclear medicine investigations in patients with neurocognitive disorders.